× Industry Reports Services Press Release Contact us About us

European Animal Model Market revenue to reach $3.5 Bn by 2027

 Request a sample

European Animal Model Market size is projected to exceed USD 3.5 billion by 2027, according to a latest forecast report by Graphical Research.

Large number of applications in healthcare domain will spur the demand for animal models, thereby stimulating the animal model market growth. Several areas of applications such as testing efficacy and safety of drugs, and disease prognosis in biomedical research find the use of animal models. Animal models such as rats, monkeys, guinea pigs and mice have also proven to be effective teaching tools and in providing the understanding of development of treatment strategies and disease pathogenesis. Furthermore, research studies to search the evidence of paravascular circulation in central nervous system (CNS) have been conducted on animal models. Animal models also play an important role in the area of infectious arthritis and are increasingly being used by biopharmaceutical companies to test the toxicity of drugs.

Based on animal type, the animal model market is segmented as mice, rats, fish, birds, cattle, pigs, amphibians, guinea pigs, dogs, cats, rabbits, monkeys, sheep, hamsters and others. Guinea pig segment is anticipated to expand at a CAGR of 9.5% from 2021 to 2027.  Guinea pigs as animal models are widely used for studying IUGR and lung injury associated with prematurity. In addition, guinea pig models have been used to create models of TB transmission owing to their exceptional susceptibility to infection with inhaled mycobacteria. The guinea pig is also broadly utilized to offer organs and tissues for research and development. Guinea pig blood components are extensively used research to develop novel medicines. These animals have provided over 23 Nobel prizes for medicines with research leading to the discovery of adrenaline, the tuberculosis bacterium, development of vaccines for diphtheria, Vitamin C, etc. These factors are potentially fostering the demand and production of guinea pigs to be used as animal models.

Based on technology, the Europe animal model market is segmented as CRISPR, microinjection, embryonic stem cell injection, nuclear transfer and other. Nuclear transfer segment was valued at over USD 442 million in 2020 and is anticipated to expand at a CAGR of 5.2% from 2021 to 2027. Somatic cell nuclear transfer technique has a huge potential for generation of animal models. Introduction of nuclease-mediated genome editing is advantageous for in targeted mouse genome editing technology, thereby leading to wide acceptance of nuclear transfer technique. High efficiency, ease of design, and construction are some additional factors augmenting the adoption of nuclear transfer technique. Nuclear transfer is used to produce a genetically identical clone of an animal. It commonly includes the placement or transfer of a donor nucleus into the cytoplasm of an enucleated oocyte. Nuclear transfer has offered a technique to produce transgenic animal models through the introduction of exogenous DNA.

Based on application, the European animal model market is bifurcated as research and development, production and quality control, academics, preclinical applications and others. Academics segment is anticipated to expand at 6.6% CAGR from 2021 to 2027. Increasing focus on education leading to increase in number of educational institutions has augmented the demand for animal models. Animal models are an important part of academics as they are used in educating about the human anatomy to the students. Animal models are also used in academics for conducting experiments. Academic institutions are focused to provide a strong theoretical background coupled with the wider practical context and highlight their several ethical inferences. Animal experiments are an integral part of the pharmacology education at medical colleges. It involves the use of animals in experimentation in research, training, and education. A larger number and a better variety of animals are used in in applied research that intends to answer precise questions and that are usually performed in the pharmaceutical industry or by universities.

Browse detailed statistical insights from the report, “Europe Animal Model Market Forecast 2027 By Application (Research & Development {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}, Production and Quality Control, Academics, Preclinical Applications {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}), By Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-government}, Academic and Research Institutes, Contract Research Organizations (CRO)), Research Report, Regional Outlook (Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

https://www.graphicalresearch.com/industry-insights/1853/europe-animal-model-market

Based on use, the Europe animal model market is segmented as human and veterinary. Veterinary segment held considerable market share in 2020 and was valued at more than USD 473 million. The majority market share is owing to growing demand for effective therapeutics to treat disorders prevalent in animals including seizures. Growing animal research in veterinary medicine has proved to save lives of companion animals. Veterinary drugs are also needed to improve the health of sick pets. Animal research aids not only humans, but also the animals themselves. For instance, animals such as cats and dogs are living better and longer lives due to vaccines for parvo, rabies, and feline leukemia among. Animal models have been responsible for the various significant knowledge developments in veterinary medicine. They are widely used to examine the basic principles of life, improve an understanding of animal physiology, anatomy, and pharmacology among others.

Based on end-use, the Europe animal model market is segmented as companies, organizations, academic and research institutes and contract research organizations (CROs). Organizations segment held significant market share in 2020 and was valued at more than USD 707 million. Non-government and government organizations are engaged in generation of animal models as they spread awareness pertaining to animal care that is augmenting the adoption of animal models. These organizations also supply animal models to biotechnology companies.  The use of animal models is highly preferred in these organizations owing to the utilization of animal models in research field is superior to non-animal options. Furthermore, non-government and government organizations focused that researchers must participate in community outreach opportunities to constantly receive funding. Through medical history, evidence proposes that animal-based research produces outcomes helpful to human medicine. The animal model cannot be easily substituted by testing performed outside of an organism, thereby surging the demand for animal models.

Germany animal model market is anticipated to expand at a CAGR of 5.8% and foresee a similar growth trend in the coming years. The higher market growth in the country is owing to increase in number of biomedical research institutions. Increasing awareness to develop effective drugs, rising prevalence of diseases, expenditure on healthcare and improving economy of the country are the major factors contributing to the Europe animal model market growth. In Germany, animal research is mainly approved in the areas of veterinary medicine and basic research. This research is also required to classify factors that pose a risk to the environment. The European Animal Research Association uses animals such as monkeys, pigs, and ferrets among others for effective outcomes in biomedical research.

European animal model market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million and Units from 2016 to 2027, for the following segments:

Europe Market, By Animal Type

  • Mice
  • Rats
  • Fish
  • Birds
  • Cattles
  • Pigs
  • Amphibians
  • Guinea Pigs
  • Dogs
  • Cats
  • Rabbits
  • Monkeys
  • Sheep
  • Hamsters
  • Others

Europe Market, By Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Others

Europe Market, By Application

  • Research & Development
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Obesity
    • NAFLD/NASH
    • Renal disease
    • Diabetic eye disease
    • Fibrosis
    • Microbiome
    • Others
  • Production and Quality Control
  • Academics
  • Preclinical Applications
    • Infectious Disease
    • Immunological Diseases
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Genetic Diseases
    • Neurological Diseases
    • Obesity
    • NAFLD/NASH
    • Renal disease
    • Diabetic eye disease
    • Fibrosis
    • Microbiome
    • Others
  • Others

Europe Market, By Use

  • Human
  • Veterinary

Europe Market, By End-use

  • Companies
    • Pharmaceutical
    • Biotechnology
    • Cosmetics
    • Others
  • Organizations
    • Government
    • Non-government
  • Academic and Research Institutes
  • Contract Research Organizations (CRO)

The above information has been provided for the following countries:

  • Europe 
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Switzerland
    • Netherlands
    • Czech Republic
    • Poland
    • Belgium
    • Finland
    • Hungary
    • Denmark
    • Ireland
    • Sweden
    • Others